## Abstract The chondrogenic differentiation of bone marrow‐derived human mesenchymal stem cells (MSCs) in a collagen type I hydrogel, which is in clinical use for matrix‐based autologous chondrocyte transplantation (ACT), was investigated. Collagen hydrogels with 2.5 × 10^5^ MSCs/mL were fabricate
Chondrogenic differentiation and immunological properties of mesenchymal stem cells in collagen type I hydrogel
✍ Scribed by Tun Yuan; Li Zhang; Li Feng; HongSong Fan; XingDong Zhang
- Publisher
- American Institute of Chemical Engineers
- Year
- 2010
- Tongue
- English
- Weight
- 850 KB
- Volume
- 26
- Category
- Article
- ISSN
- 8756-7938
- DOI
- 10.1002/btpr.484
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Allogeneic mesenchymal stem cells (MSCs) are regarded as promising seed cells for engineering cartilage. However, few researches have covered the immune properties of seeded MSCs. Collagen has been considered as good scaffold, whether it has inherent chondrogenic inducibility for MSCs is still in debate. In this study, engineering grafts are constructed by neonatal rabbit MSCs and collagen Type I hydrogel. After periods of culture, the appearance of chondroid tissue in the grafts and the cartilage matrix‐specific genes expressions of seeded cells prove the inducibility of collagen hydrogel, even if the growth factors are absence. With the differentiation, immunological properties of MSCs are changing. The expressions of main histocompatibility complex (MHC) molecules increase and the ability to inhibit the proliferation of activated lymphocytes may be declined. But to a large extent, it keeps the low stimulating to allogeneic lymphocytes and the small absolute value of MHCs. The changes are adverse for avoiding inflammation and rejection. Therefore, suitable scaffold and engineering strategies should be selected. For the grafts based on Collagen I hydrogel and MSCs, a longer culture period might not be necessary. To maintain the immune regulation, a higher initial MSCs density in engineering grafts may be more meaningful. © 2010 American Institute of Chemical Engineers Biotechnol. Prog., 2010
📜 SIMILAR VOLUMES
## Abstract Bone marrow mesenchymal stem cells (MSCs) are candidate cells for cartilage tissue engineering. This is due to their ability to undergo chondrogenic differentiation after extensive expansion in vitro and stimulation with various biomaterials in three‐dimensional (3‐D) systems. Collagen
## Abstract An injectable hydrogel composite consisting of oligo(poly(ethylene glycol)fumarate) (OPF) and gelatin microparticles has been developed as a novel carrier system for cells and growth factors. Rabbit marrow mesenchymal stem cells (MSCs) and gelatin microparticles (MPs) loaded with insuli
## Abstract The study was initially designed to differentiate human bone marrow–derived mesenchymal stem cells (MSC) into chondrocyte‐like cells, for use in tissue engineering. We cultured MSCs in defined chondrogenic medium as pellet cultures supplemented with transforming growth factor (TGF)‐β1 o
Mesenchymal stem cells (MSCs), precursor cells resident in the bone marrow, have the capacity to differentiate into bone, cartilage, fat, and connective tissue. We have recently reported that MSCs from "healthy" donors differ from cells obtained from osteoporotic postmenopausal women in their prolif